The potential in the US for the withdrawal of oral phenylephrine’s indication as a nasal decongestant comes at an opportune time for xylitol nasal spray marketer Xlear Inc.
“We already had plans to increase advertising and messaging to the market during this season,” said Joel
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?